Leading Companies Launch American Alliance for Biomanufacturing (AAB) to Bolster U.S. Industrial Leadership

New coalition aims to accelerate U.S. capabilities in scalable, secure biomanufacturing

WASHINGTON, May 21, 2025 /PRNewswire/ -- Today marks the official launch of the American Alliance for Biomanufacturing (AAB), a new coalition of industry leaders committed to advancing U.S. leadership in biomanufacturing innovation, competitiveness, and resilience.

The Alliance brings together essential stakeholders from across the industrial biomanufacturing ecosystem to address critical challenges and opportunities in a rapidly evolving sector that is increasingly vital to American economic and national security, and public health.

The formation of AAB comes at a pivotal moment, with the National Security Commission on Emerging Biotechnology (NSCEB) calling for a coordinated, whole-of-government strategy to ensure U.S. global leadership in industrial biomanufacturing.

Ajikumar "Aji" Parayil, Chief Executive Officer, Manus:

"Industrial biomanufacturing is no longer just a scientific opportunity – it is a strategic imperative. The Alliance is a focused, execution-oriented step toward a much-needed national strategy that aligns innovation with job creation, supply chain resilience, and global competitiveness. At Manus, we deliver bioalternative production at scale in the U.S. – fostering sustainable economic growth, revitalizing rural communities, and creating real-world impact."

Chris Abbott, CEO Pivot Bio:

"Through strengthening American biomanufacturing, we can deliver better-performing, lower-cost agricultural inputs that do not rely on complex international supply chains. That means more money in farmers' pockets, less risk to U.S. supply chains, and cleaner air and water for us all."

Tue Michelsen, President of Novonesis North America:

"Biomanufacturing gives us the tools to solve real problems in real communities. We are talking about higher crop yields from healthier soil, better animal welfare, food that stays fresher longer, and cleaner air and water. For everyday Americans, that means more nutritious food on the table, fewer chemicals in our environment, and products that support better health and quality of life. We are proud to be a founding member of the American Alliance for Biomanufacturing because we believe biology is the key to solving some of the world's greatest challenges."

Bill Brady, Co-Founder and CEO, Kula Bio:

"Kula Bio is proud to be part of the American Alliance for Biomanufacturing and looks forward to helping drive this strategic industry toward global leadership. We feel strongly that the United States can lead in the global biomanufacturing revolution providing the world with critically needed innovation to reduce input cost, build high paying jobs, and improve sustainability for future generations. We welcome the focus and attention that the American Alliance for Biomanufacturing will bring to help seize this opportunity for continued American innovation and leadership."

Leticia Gonçalves, President, IFF Health & Biosciences:

"The launch of the American Alliance for Biomanufacturing is a bold step toward securing America's leadership in the next industrial revolution. At IFF, we are proud to support this effort as it aligns with our commitment to advancing sustainable, science-driven innovation. By harnessing the power of nature to manufacture the materials, fuels, and products of tomorrow, we are driving progress and building a more resilient, competitive, and bio-based economy."

Justin van Rooyen, President, Lallemand Biofuels & Distilled Spirits:

"We at Lallemand Biofuels and Distilled Spirits (LBDS) are pleased to be an inaugural member of the American Alliance for Biomanufacturing (AAB) dedicated to advancing the U.S. bioeconomy. The objectives are clear: supercharging U.S. demand for bio-based products and technologies and ensuring market readiness for both existing and novel bioproducts. We wholeheartedly support the mission to enhance U.S. global competitiveness, driving innovation and sustainability, and positioning the U.S. as a leader in the bio-based industry."

Dr. Jennifer Holmgren, Chair and CEO, LanzaTech Global:

"Biomanufacturing strengthens the U.S. manufacturing sector—particularly in rural communities—advances innovation and enhances the value of local resources. LanzaTech proudly serves as a launch member of the American Alliance for Biomanufacturing and applauds the AAB's mission to accelerate the commercial deployment of bio-based products, fuels, and technologies."

Mark Warner, Co-Founder and CEO of Liberation Labs:

"Most US-invented biotechnologies end up being manufactured overseas in decades old facilities built for different purposes, raising costs and impacting quality. The US has an immediate opportunity to create a durable leadership position in industrial biomanufacturing by onshoring production. With the AAB's leadership we believe we can get there."

Joshua Lachter, Co-Founder and CBO, Synonym:

"If America is to indeed experience an industrial renaissance and once again lead the world in producing the next generation of stuff, biomanufacturing leadership will be a crucial part of the story. Synonym is honored to be a founding member of the American Alliance for Biomanufacturing, working to ensure that the United States retains its dominance in this vital industry."

Rob Walther, Vice President of Federal Advocacy, POET:

"America's biorefineries are producing an entire suite of sustainable bioproducts, driving innovation, and creating valuable goods like bioplastics and bio-based chemicals. The bioeconomy is poised to boost U.S. agriculture and our rural communities as well as increase the production of sustainable, homegrown materials demanded throughout the world."

Brian Brazeau, Partner, Ferment Co:

"As a venture creation fund, at Ferment we champion biomanufacturing because it solves real-world problems in a wide range of markets today and offers economical solutions for tomorrow. We are proud to be a founding member of this alliance to accelerate demand and drive market adoption—aligning with our mission to build new companies that tackle hard problems with scalable, biology-driven innovation."

Nelson Barton, EVP, CTO, Geno:

"Geno is aligned with the Alliance's mission to accelerate the growth of US-based biomanufacturing, reducing barriers and shortening timelines to commercial plants, bringing greater resilience to both domestic and global supply chains."

Biomanufacturing – which utilizes biological systems to manufacture products spanning sectors as diverse as energy, defense, agriculture, chemicals, ingredients, sweeteners, materials, fabrics, and nutrition – is a $20B global industry poised to grow exponentially. In its report, the NSCEB implored U.S. policymakers get behind the development of a robust U.S. bio-industrial economy: "the choice is stark: do nothing and accept defeat or act swiftly and give America a fighting chance."

"Biomanufacturing technologies are advancing, enabling the production of stickier resins, better fertilizers, healthier ingredients, more durable nylon, and sustainable plastics," said Brooke Coleman, Executive Director of the Alliance. "By working together, and recognizing global realities, we can ensure that the United States maintains its competitive edge in developing and scaling the biological products and processes that will define the 21^st century economy."

The Alliance will focus on two key objectives: (1) supercharging U.S. demand for bio-based products and technologies; and (2) ensuring market readiness for existing and novel bioproducts. It will also seek to strengthen domestic supply chains for biological materials, equipment, and technologies to enhance U.S. global competitiveness.

For more information about the American Alliance for Biomanufacturing, visit www.aabio.org.

SOURCE American Alliance for Biomanufacturing